You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Boehringer Ingelheim
Merck
Medtronic
McKesson

Last Updated: April 3, 2020

DrugPatentWatch Database Preview

HYDROXYPROGESTERONE CAPROATE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Hydroxyprogesterone Caproate patents expire, and when can generic versions of Hydroxyprogesterone Caproate launch?

Hydroxyprogesterone Caproate is a drug marketed by Akorn, Allergan, Am Regent, Aspen, Aspen Global Inc, Eugia Pharma, Slayback Pharma Llc, and Sun Pharm. and is included in eleven NDAs.

The generic ingredient in HYDROXYPROGESTERONE CAPROATE is hydroxyprogesterone caproate. There are twelve drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the hydroxyprogesterone caproate profile page.

US ANDA Litigation and Generic Entry Outlook for Hydroxyprogesterone Caproate

A generic version of HYDROXYPROGESTERONE CAPROATE was approved as hydroxyprogesterone caproate by ASPEN GLOBAL INC on August 24th, 2015.

  Start Trial

Drug patent expirations by year for HYDROXYPROGESTERONE CAPROATE
Drug Prices for HYDROXYPROGESTERONE CAPROATE

See drug prices for HYDROXYPROGESTERONE CAPROATE

Recent Clinical Trials for HYDROXYPROGESTERONE CAPROATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityPhase 4
Aswan University HospitalN/A
University of North Carolina, Chapel HillPhase 3

See all HYDROXYPROGESTERONE CAPROATE clinical trials

Recent Litigation for HYDROXYPROGESTERONE CAPROATE

Identify potential future generic entrants

District Court Litigation
Case NameDate
Antares Pharma Inc. v. Medac Pharma Inc.2014-07-21

See all HYDROXYPROGESTERONE CAPROATE litigation

Pharmacology for HYDROXYPROGESTERONE CAPROATE
Drug ClassProgestin
Synonyms for HYDROXYPROGESTERONE CAPROATE
(1S,11S,15S,2R,10R,14R)-14-acetyl-2,15-dimethyl-5-oxotetracyclo[8.7.0.0<2,7>.0 <11,15>]heptadec-6-en-14-yl hexanoate
(1S,2R,10R,11S,14R,15S)-14-acetyl-2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-14-yl hexanoate
(8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl hexanoate
[(8R,9S,10R,13S,14S,17R)-17-ethanoyl-10,13-dimethyl-3-oxidanylidene-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] hexanoate
17 alpha-hydroxyprogesterone caproate
17-.alpha.-Hexanoyloxypregn-4-ene-3,20-dione
17-((1-Oxohexyl)oxy)pregn-4-ene-3,20-dione
17-alpha-Hexanoyloxypregn-4-ene-3,20-dione
17-alpha-Hydroxy progesterone n-caproate
17-alpha-hydroxy-progesterone caproate
17-alpha-Hydroxyprogesterone caproate
17-alpha-Hydroxyprogesterone hexanoate
17-Caproxyprogesterone
17-Caproyloxyprogesterone
17-Hydroxypregn-4-ene-3,20-dione caproate
17-Hydroxypregn-4-ene-3,20-dione hexanoate
17-OHPC
17.alpha.-Hydroxypregn-4-ene-3,20-dione caproate
17.alpha.-Hydroxypregn-4-ene-3,20-dione hexanoate
17.alpha.-Hydroxyprogesterone caproate
17.alpha.-Hydroxyprogesterone hexanoate
17.alpha.-Hydroxyprogesterone n-caproate
17|A-Hydroxyprogesterone caproate
17|A-Hydroxyprogesterone hexanoate
17a-hydroxyprogesterone caproate
17alpha-Caproyloxypregn-4-ene-3,20-dione
17alpha-Caproyloxyprogesterone
17alpha-hexanoyloxy-4pregnene-3,20-dione
17alpha-Hydroxypregn-4-ene-3,20-diene Caproate
17alpha-Hydroxyprogesteron-Caproat
17alpha-Hydroxyprogesterone caproate
17alpha-Hydroxyprogesterone caproate [Progestins]
17alpha-Hydroxyprogesterone hexanoate
17alpha-Hydroxyprogesterone hexanoate, >=98%
17alpha-Hydroxyprogesterone n-caproate
17alpha-Hydroxyprogesterone-17alpha caproate
276F2O42F5
3,20-Dioxo-4-pregnen-17alpha-yl hexanoat
3,20-Dioxopregn-4-en-17-yl hexanoate
3,20-Dioxopregn-4-en-17.alpha.-yl caproate
3,20-Dioxopregn-4-en-17.alpha.-yl hexanoate #
3,20-Dioxopregn-4-en-17alpha-yl caproate
630-56-8
630H568
A834188
ACN-037582
AKOS005267159
ARONIS24417
BCP16081
BDBM70293
C-22216
C08148
Caproate d'hydroxyprogesterone
Caproate d'hydroxyprogesterone [INN-French]
Caproato de hidroxiprogesterona
Caproato de hidroxiprogesterona [INN-Spanish]
Caproic acid hydroxyprogesterone
CAS-630-56-8
CC-29446
CHEBI:5812
CHEMBL1200848
cid_169870
Corlutin L.A.
CTK6D6716
D00949
DB06789
Delalutin
Delalutin (TN)
Deluteval 2X (Salt/Mix)
Depo-Proluton
DOMWKUIIPQCAJU-LJHIYBGHSA-N
DSSTox_CID_23915
DSSTox_GSID_43915
DSSTox_RID_80089
DTXSID6043915
Duraluton
EINECS 211-138-8
Estralutin
Gesterol LA 250
Gestiva
GS-3233
hexanoic acid [(8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] ester
Hexanoic acid, ester with 17-hydroxypregn-4-ene-3,20-dione
HMS2230L08
Hormofort
HY-B0742
Hydroxyprogesterone caproate (JAN/USP/INN)
Hydroxyprogesterone caproate [USP:INN:JAN]
Hydroxyprogesterone caproate, United States Pharmacopeia (USP) Reference Standard
Hydroxyprogesterone hexanoate
Hydroxyprogesteroni caproas
Hydroxyprogesteroni caproas [INN-Latin]
Hylutin
Hylutin (TN)
Hyproval
Hyproval P.A.
Hyproval-PA
Hyroxon
Idrogestene
Idroprogesterone caproato
Idroprogesterone caproato [DCIT]
Kaprogest
Lewntogest
Lutate
Luteocrin
Luteocrin depot
Lutopron
Makena
Makena (TN)
MLS000028438
MLS001148643
MLS002207289
NCGC00021268-03
NCGC00021268-04
NCGC00255784-01
Neolutin
Neolutin forte
NSC-17592
NSC17592
Opera_ID_1479
Oxiprogesterone Caproate
Pregn-4-ene-3, 17-[(1-oxohexyl)oxy]-
Pregn-4-ene-3, 17-hydroxy-, hexanoate
Pregn-4-ene-3,20-dione, 17-((1-oxohexyl)oxy)-
Pregn-4-ene-3,20-dione, 17-[(1-oxohexyl)oxy]-
Pregn-4-ene-3,20-dione, 17-hydroxy-, hexanoate
Primolut Depot
Proge
Progesterone caproate
Progesterone retard pharlon
Progesterone, 17-hydroxy-, hexanoate
Progesterone, hexanoate
Proluton Depot
Q-201222
Q3792032
Relutin
s4674
SBB080822
SC-74381
SCHEMBL5330
SMR000058336
SR-01000003075
SR-01000003075-3
ST075196
Syngynon
Teralutil
Tox21_113502
Tox21_113502_1
Tox21_302333
UNII-276F2O42F5
ZINC4083606

US Patents and Regulatory Information for HYDROXYPROGESTERONE CAPROATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn HYDROXYPROGESTERONE CAPROATE hydroxyprogesterone caproate INJECTABLE;INJECTION 018004-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Eugia Pharma HYDROXYPROGESTERONE CAPROATE hydroxyprogesterone caproate SOLUTION;INTRAMUSCULAR 211071-001 Apr 16, 2019 AP RX No No   Start Trial   Start Trial   Start Trial
Am Regent HYDROXYPROGESTERONE CAPROATE hydroxyprogesterone caproate SOLUTION;INTRAMUSCULAR 210723-001 Jun 21, 2018 AP RX No No   Start Trial   Start Trial   Start Trial
Sun Pharm HYDROXYPROGESTERONE CAPROATE hydroxyprogesterone caproate SOLUTION;INTRAMUSCULAR 208381-001 Apr 9, 2019 AP1 RX No No   Start Trial   Start Trial   Start Trial
Eugia Pharma HYDROXYPROGESTERONE CAPROATE hydroxyprogesterone caproate SOLUTION;INTRAMUSCULAR 211070-001 Apr 16, 2019 AP1 RX No No   Start Trial   Start Trial   Start Trial
Allergan HYDROXYPROGESTERONE CAPROATE hydroxyprogesterone caproate INJECTABLE;INJECTION 017439-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Boehringer Ingelheim
Merck
Medtronic
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.